Philips secures FDA approval for a new pulse oximeter addressing racial bias with improved accuracy...
Heart failure management is shifting as pharmacists take on a larger role. Discover how they...
Medicare introduces a $50 monthly copay for GLP-1 weight-loss drugs, offering affordable access to eligible...
FDA approves Leqembi home administration. Learn about the new starting dosage regimen for subcutaneous lecanemab...
Learn why bispecific T-cell therapy for multiple myeloma may face access restrictions and how patient...
A groundbreaking drug for resistant hypertension offers hope to patients unresponsive to standard treatments, targeting...